WHO vaccine-preventable diseases: monitoring system. 2014 global summary

Last updated 15-Jul-2014 (Data received as of 8-Jul-2014)
Next overall update Fall 2014
EPI mother and child logo         
Select a country

Development status: Developed economy GNI / capita (US$): 1 Infant (under 12 months) mortality rate: 82
GDP / capita (US$): 1 Child (under 5 years) mortality rate: 92

Population data in thousands3

  2013  2012  2011  2010  2009  2000  1990  1980 
Total population 2'050  2'060  2'073  2'091  2'112  2'371  2'664  2'513 
Births 23  23  23  23  22  19  36  36 
Surviving infants 22  22  22  22  22  19  35  35 
Pop. less than 5 years 110  109  109  109  108  98  208  173 
Pop. less than 15 years 304  299  296  296  297  423  571  515 
Female 15-49 years 480  489  497  506  518  590  651  646 

Number of reported case

(Click for retrospective incidence data for Latvia)
Diphtheria 14  264 
Japanese encephalitis
Measles 21 
Mumps 15  41  10  1'949 
Pertussis 201  257  10  135  129 
Polio*
Rubella 62 
Rubella (CRS)
Tetanus (neonatal)
Tetanus (total)
Yellow fever
* Polio refers to all polio cases (indigenous or imported), including polio cases caused by vaccine derived polio viruses (VDPV);"
"it does not include cases of vaccine-associated paralytic polio (VAPP) and cases of non polio acute flaccid paralysis [AFP]).

Percentage target population vaccinated by antigen

Hovering over an antigen reveals its fuller definition
  Most recent coverage survey4  

Official country estimates5

  (Click for retrospective coverage estimates data for Latvia)
Vaccine year result method % card seen                                                
BCG          97  97  94  92  96  100 
DTP1          96  95  95  96  92  100 
DTP3          95  92  93  91  96  96 
HepB_BD          97  98 
HepB3          95  91  90  91  93  95 
Hib3          95  91  92  90  95  79 
JapEnc         
MCV          96  90  88  92  94  97 
MCV2          95  95  91  94  97  90 
PCV1          88  84  88  64 
PCV3          78  82 
Pol3          95  92  93  91  96  96 
Rota1         
Rota_last         
Rubella1          96  90  99  93  96 
TT2plus         
PAB         
VAD1         
YFV         
  ° indicates that more than 1 survey occurred that year

  Next update: July 2015

WHO-UNICEF estimates6

  (Click for full retrospective WHO-UNICEF coverage estimates data for Latvia)
BCG 96  97  94  92  96  99 
DTP1 96  95  95  96  98  99 
DTP3 95  92  93  91  96  96 
HepB3 95  91  90  91  93  95 
HepB_BD 97  98 
Hib3 95  91  92  90  95  79 
MCV 96  90  88  92  94  97 
MCV2 95  95  91  94  96  90 
PCV3 88  78  82 
Pol3 95  92  93  91  96  96 
Rota_last

Number of districts in the country 119  Proportion of
districts reporting
DTP3 coverage:
% of coverage reports received at national
level vs number of reports expected
100 
   
/
|
|
\
Greater or equal to 90% 0
From 80 to 89% 0
From 50 to 79% 0
Less than 50% 0
Proportion of districts
not reporting DTP3 coverage
100
 

Immunization Schedule (2013 or latest available)

Hovering over an antigen reveals its fuller definition
Vaccine Schedule Entire country Comment
BCG 2-5 days; Yes
DTaPHibHepIPV 2, 4, 6, 12-15 months; Yes
DTaPHibIPV 2, 4, 6 months; Yes risk group
DTaPIPV 7 years; Yes
HepB birth; +1, +2, +12-15 months; Yes for risk newborns or Y14 (x3 doses)
HPV 12 years (x3); Yes
MMR 12-15 months; 7 years; Yes
Pneumo_conj 2, 4, 12-15 months; Yes
Td Yes adults
TdIPV 14 years; Yes
Varicella 12-15 months; Yes

Immunizaton indicators

Indicator Expected answer 2013  2012  2011  2010  2009  2008  2007 

Planning and management

Has the country a Multi-Year Plan (MYP) for immunization? Yes/No/NR Yes  Yes  No  Yes  Yes  Yes  Yes 
What years does the MYP cover? number 2012-2014  2012-2014    2008-2010       
Nº of districts with microplans that include activities to raise immunization coverage number     NA  NA  NA     

National Immunization Advisory Mechanism

Has the country a standing technical advisory group on immunization (NITAG)? Yes/No/NR Yes  Yes  Yes  Yes       

System performance

Total Nº districts in country number 119  119  119  33  33  33  33 
Nº districts with DTP3 coverage >=80% number 27  32  33 
% of districts with DTP3 coverage >=80% From 0 to 100% 82  97  100 
Nº districts with measles (MCV1) coverage >=95% number       17    30   
% of districts with MCV1 coverage >=95% From 0 to 100%       52    91   

Safety

Has the country a vaccine adverse events review committee? Yes/No/NR/ND No  No  No  No       
Is there a national system to monitor adverse events following immunization (AEFI)? Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  Yes 

Finance

Estimated percentage of routine vaccines funded by Government From 0 to 100% 91  100  100  100  100    100 

Sources

Unless otherwise specified, data provided by Member States through WHO-UNICEF Joint Reporting Form and WHO Regional offices.
 1  "The 2013 World Bank Development Indicators Online", GDP per capita is PPP adjusted.
 2  World Health Statistics 2013, data for 2012
 3  "United Nations, Population Division. The World Population Prospects - the 2012 revision". New York, 2013.
 4  UNICEF/WHO survey database
 5  If no official estimate is available, the administrative coverage is reported. '*' indicates coverage over 99.5%.
 6  WHO-UNICEF estimates.